Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | FLJ22184 |
Upstream (Parents) |
---|
(<<) BCAM → FLJ22184 |
(<<) CASP8 → FLJ22184 |
(<<) CASP9 → FLJ22184 |
(<<) CSTA → FLJ22184 |
(<<) ENO2 → FLJ22184 |
(<<) FGFR3 → FLJ22184 |
(<<) GNG10 → FLJ22184 |
(<<) HSPA5 → FLJ22184 |
(<<) IDI1 → FLJ22184 |
(<<) ITGAV → FLJ22184 |
(<<) MIA3 → FLJ22184 |
(<<) MKNK2 → FLJ22184 |
(<<) MTHFD2 → FLJ22184 |
(<<) PALM → FLJ22184 |
(<<) PHLDA1 → FLJ22184 |
(<<) PIK3CB → FLJ22184 |
(<<) PIP5K1C → FLJ22184 |
(<<) PRKAB1 → FLJ22184 |
(<<) PRKACB → FLJ22184 |
(<<) RASA1 → FLJ22184 |
(<<) SF3A2 → FLJ22184 |
(<<) SH3GL1 → FLJ22184 |
(<<) SHC2 → FLJ22184 |
(<<) SLC16A6 → FLJ22184 |
(<<) TCOF1 → FLJ22184 |
(<<) UBQLN2 → FLJ22184 |
(<<) ZNF205 → FLJ22184 |
Downstream (Children) |
---|
FLJ22184 → ERBB2 (>>) |
FLJ22184 → HCN2 (>>) |
FLJ22184 → HK2 (>>) |
FLJ22184 → MAP6D1 (>>) |
FLJ22184 → MMP15 (>>) |
FLJ22184 → RHBDL1 (>>) |